Incomplete Kawasaki Disease in a Child with COVID-19

Indian Pediatrics - Tập 57 - Trang 680-681 - 2020
Elvia I. Rivera-Figueroa1, Roberto Santos2, Scott Simpson3, Padma Garg1
1Division of Pediatric Critical Care Medicine, University of Mississippi Medical Center, Jackson, USA
2Division of Pediatric Infectious Disease, University of Mississippi Medical Center, Jackson, USA
3Division of Pediatric Cardiology, University of Mississippi Medical Center, Jackson, USA

Tài liệu tham khảo

Son MBF, Newburger JW. Kawasaki disease. Pediatr Rev. 2018;39:78–90. COVID-19 Treatment Guidelines Panel. Coronavirus Diseases 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available from: https://www.covid19treatmentguidelines.nih.gov/. Accessed May 8, 2020. Chiotos K, Hayes M, Kimberlin DW, Jones SB, James SH, Pinninti SG, et al. Multicenter Initial Guidance on Use of Antivirals for Children With COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc. 2020. Apr 22 [published online ahead of print]. Available from: https://academic-oup.com/jpids/advance-article/doi/10.1093/jpids/piaa045. Accessed May 8, 2020. Kanegaye JT, Wilder MS, Molkara D, Frazer JR, Pancheri J, Tremoulet AH, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123:e783–9. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J, et al. COVID-19 and Kawasaki disease: Novel virus and novel case. Hosp Pediatr. 2020 Apr 7. https://hosppeds.aappublications.org/content/early/2020/04/06/hpeds.2020-0123.long. Accessed May 8, 2020.